ENDRA LIFE SCIENCES INC (NDRA) Stock News

NASDAQ:NDRA - US29273B5003 - Common Stock

4.27 USD

+0.01 (+0.23%)

Last: 9/5/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

NDRA Latest News, Press Relases and Analysis

All

Press Releases

23 days ago - By: ENDRA Life Sciences Inc.

ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results

a month ago - By: Benzinga - Mentions: OPRX NTRA SRTS IOVA ...

12 Health Care Stocks Moving In Thursday's After-Market Session

2 months ago - By: Benzinga - Mentions: PROK ABVE BSLK SKBL ...

US Stocks Mixed; Small Business Sentiment Falls In June

3 months ago - By: ENDRA Life Sciences Inc.

ENDRA’s Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard

4 months ago - By: ENDRA Life Sciences Inc.

ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results

5 months ago - By: ENDRA Life Sciences Inc.

ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies

5 months ago - By: ENDRA Life Sciences Inc.

ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update

10 months ago - By: ENDRA Life Sciences Inc.

ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

10 months ago - By: ENDRA Life Sciences Inc.

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update

10 months ago - By: ENDRA Life Sciences Inc.

Study Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024

10 months ago - By: ENDRA Life Sciences Inc.

ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent